Brookline Capital Markets Downgrades CervoMed (CRVO) to Hold citing RewinD-LB Topline Data Failure
Tweet Send to a Friend
(Updated - December 10, 2024 11:37 AM EST)
Brookline Capital Markets analyst Tyler Bussian downgraded CervoMed (NASDAQ: CRVO) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Brookline Capital Markets analyst Tyler Bussian downgraded CervoMed (NASDAQ: CRVO) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
